Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

NIAAA to study gabapentin enacarbil for the treatment of alcohol use disorder

Sep. 12, 2014

NIDA awards grant to support completion of phase IIa trial of ibudilast in opioid dependence

Sep. 9, 2014

Cleveland BioLabs clear to submit pre-EUA for entolimod

Sep. 4, 2014

Aldea Pharmaceuticals closes Series B financing

Aug. 26, 2014

Aeolus files IND for acute radiation syndrome candidate AEOL-10150

Aug. 22, 2014

MediciNova discloses results from phase IIa study of ibudilast in opioid dependence

Aug. 20, 2014

NIPER reports novel PON 1 enzymes

Aug. 14, 2014

Lightlake Therapeutics receives funding for development of intranasal naloxone

Aug. 5, 2014

Evzio auto-injector available in the U.S. for emergency treatment of opioid overdose

July 11, 2014

Presentation of data on Aeolus' AEOL-10150 medical countermeasure

July 4, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...